Siloam Hospitals and Roche Indonesia have announced a strategic partnership to enhance breast cancer care standards in the country. The collaboration focuses on improving early detection, treatment, and patient support through advanced medical technologies and specialized services.
Breast cancer remains the most common cancer among women in Indonesia, with approximately 66,000 new cases diagnosed each year. The partnership aims to address the growing demand for quality care by integrating Roche’s diagnostic tools and therapeutic solutions with Siloam Hospitals’ clinical expertise.
The initiative includes training programs for healthcare professionals and the introduction of innovative treatment protocols. This collaboration reflects a broader effort to improve cancer care infrastructure and increase access to life-saving treatments across Indonesia.
The partnership is expected to benefit thousands of patients by offering more accurate diagnoses and personalized treatment options, ultimately contributing to better health outcomes for women in the region.
